Beijing Xinkaiyuan Pharmaceutical Technology Co., Ltd., established on 2014-03-20, Business scope includes biotechnology promotion;Medical Research;technology development;technical consulting;technology transfer;Import and export,Technology Import and Export,Agent import and export.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policy of the district.)

Nanjing Wangzhixing Pharmaceutical Technology Co., Ltd., established on 2016-06-07, Business scope includes medical technology,Biotechnology,Chemical technology transfer,technical consulting;Chemical Products(Free of Hazardous Chemicals),Medical Device Sales;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Hainan General Sanyang Pharmaceutical Co. Ltd. is a company headquartered in Haikou, China and ultimately controlled by the Government of China. The firm manufactures and distributes pharmaceuticals.

IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy and water testing markets. It operates through the following segments: Companion Animal Group (CAG), Water, Livestock, Poultry and Dairy (LPD), and Other. The CAG segment provides diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment offers innovative testing solutions for easy, rapid, and accurate detection and quantification of various microbiological parameters in water. The LPD segment develops diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk and food. The Other segment is composed of products for the human point-of-care medical diagnostics market with its out-licensing arrangements. The company was founded by David Evans Shaw on December 19, 1983, and is headquartered in Westbrook, ME.

Disha Pharmaceutical Group Co., Ltd., established on 1997-04-30, Business range includes tablet,Granules,hard capsule(cephalosporins),Production and sales of small-volume injections of the company's products(The validity period is subject to the license);Chinese Herbal Medicine(Contains direct oral tablets,Processing range:Purification,cut,Fried,Broiled,steamed,cook,stew,Forging,charcoal,control)production and sales of(The validity period is subject to the license);Production and sales of health food(The scope and validity period of the license shall be subject to the Food Hygiene License);the first sort,Production and sales of Class II medical devices;the first sort,Class II medical device business;food production;food sales;Production of food additives,Sales;Import and export of goods and technologies within the filing scope;Research and development of marine biological products,Production,Sales,technology development,Technology transfer and technical consulting services;Indoor and outdoor decoration engineering construction;Inspection and testing services for drug structure confirmation;disinfection products(Free of Hazardous Chemicals),Production and sales of labor insurance products.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Part of Shanghai Shyndec Pharmaceutical Co., Ltd., Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co. Ltd. is a Chinese company located in Shangqiu. The firm manufactures and distributes pharmaceuticals and other chemicals.

Jiangsu Xiangrui Pharmaceutical Co., Ltd., established on 2003-12-18, The scope of business includes the research of chemical preparations;tablet,Capsules,Granules,Production and sales of eye drops(Operating with a drug production license);Health food sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

RedHill Biopharma Ltd. develops medicines for gastrointestinal and infectious diseases. It operates through Commercial Operations, and the Research and Development segments. The Commercial Operations segment covers all areas relating to the commercial sales and is being performed by the subsidiary in the U.S. The Research and Development segment includes the study and licensing of therapeutic candidates. Its products include Talicia, Movantik, and Aemcolo. The company was founded by Dror Ben-Asher and Ori Shilo on August 3, 2009 and is headquartered in Tel Aviv, Israel.

Jiangsu Shenlong Pharmaceutical Co., Ltd., established on 2001-02-26, Business scope includes pharmaceutical production(Production according to the items listed in the production license);Bioengineering technology development,consult,comminicate,transfer,Promotion service;medicine,Health product research,technical consulting,technology transfer;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export);Purchase of home-grown Chinese herbal medicines,wholesale,retail;Wholesale of equipment,retail;Realtor.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shenyang Yongda Pharmaceutical Co., Ltd., established on 1995-06-14, Business scope includes licensed projects:pharmaceutical production,Pharmaceutical commissioned production,Drug import and export,Drug Wholesale,food production,Health food production,food sales,Food Internet Sales,beverage production,wine production,liquor business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Health Consulting Services(Does not include medical services),Purchasing agency service,Consulting and planning service,marketing planning,Healthy food(prepackaged)Sales,Food import and export,Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Livzon Group Livzon Pharmaceutical Factory, a subsidiary of Livzon Pharmaceutical Group, Inc., is a company headquartered in China that produces and distributes Western and Chinese medicines, diet supplements, medical devices and chemical materials.

Zhejiang Zhenyuan Pharmaceutical Co., Ltd., a subsidiary of Zhejiang Zhenyuan Share Co., Ltd., is a company headquartered in Shaoxing, China. The firm manufactures and distributes pharmaceutical products. It was acquired by Zhejiang Zhenyuan Share Co., Ltd. on December 14, 2011.

Yaoyun (Xi'an) Pharmaceutical Technology Co., Ltd., established on 2018-08-27, Business scope includes general items:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Specialty Chemicals Sales(Free of Hazardous Chemicals);Disinfectant sales(Free of Hazardous Chemicals);Sales of hygiene products and single-use medical products;Drug testing equipment sales;Daily miscellaneous goods sales.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Import and export;Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Zhejiang Garden Pharmaceutical Co., Ltd. is engaged in manufacture pharmaceutical products including Xinnaojian tablets, panaxnotoginseng capsules, sucralfate tablets and Lansoprazole.The company leading product is Xinnaojian traditional chinese tablet, it can be used in the therapy of cardiovascular and cerebrovascular diseases (high blood pressure, hyperlipemia) and cytopenia caused by the teletherapy and chemotherapy of tumor. The company was founded in August, 2001 and is headquartered in Dongyang China.

Dijia Pharmaceutical Group Co., Ltd., established on 2013-03-07, The scope of business includes the development of APIs,production and sales;Development of non-sterile API,production and sales;Production of new marine biological materials,Sales and R&D;Import and export of goods and technologies within the filing scope;Research, development and transfer of medical technology,consultation service;Extraction of natural products,Research, development and transfer of separation and purification technology;from plants,Extraction and sale of natural products from ores(Items not subject to license);Fine Chemicals(Does not contain dangerous goods and other items that must be operated with a license)production and sales of;API,Export business of fine chemical products;clothing,textile,Daily necessities,Stationery,food,Production and sales of food additives;Health products,cosmetic,hygiene products,kitchen supplies,household appliances,Cleaning supplies,Sales of healthcare equipment;disinfection products(Free of Hazardous Chemicals)production and sales of;Chemical Products(Free of Hazardous Chemicals)production and sales of.(Except for items prohibited by law,Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Harbin Sansan Pharmaceutical Co., Ltd., established on 1998-09-28, Business scope includesC07-Food Production License Program:pharmaceutical production;food production;Cosmetic production.General project:Import and export;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Trademark agency;Sales of Class II Medical Devices;Sales of Class I Medical Devices;grain sales;Wholesale Fresh Vegetables;Cosmetics Wholesale;Office Equipment Sales;software sales;Sales of packaging materials and products;advertisement making;advertising;Advertising Design,acting;Conference and Exhibition Services;Business Management Consulting;Corporate Image Planning.

Alembic Ltd. engages in the pharmaceutical and real estate business. It operates through the Active Pharmaceutical Ingredient (API) and Real Estate segments. The API segment manufactures and markets fermentation and chemistry based API. The Real Estate segment involves the construction of residential and commercial real estate projects, project management, and marketing consultancy. The company was founded on July 30, 1907 and is headquartered in Vadodara, India.

Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is ARIKAYCE® (amikacin liposome inhalation suspension), which is approved in the United States for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. MAC lung disease is a rare and often chronic infection that can cause irreversible lung damage and can be fatal. Insmed's earlier-stage clinical pipeline includes INS1007, a novel oral reversible inhibitor of dipeptidyl peptidase 1 with therapeutic potential in non-cystic fibrosis bronchiectasis and other inflammatory diseases, and INS1009, an inhaled formulation of a treprostinil prodrug that may offer a differentiated product profile for rare pulmonary disorders, including pulmonary arterial hypertension.

XINCAT is a pharmaceutical manufacturing company that provides antibiotics, capsules, granules, and sustained-release tablets. Their products such as cefaclor capsules, cefaclor granules, glipizide capsules, pioglitazone hydrochloride capsules, cefuroxime axetil dispersible tablets, cefaclor sustained release tablets, loratadine hydrochloride capsules, compound paracetamol dispersible tablets, finasteride capsules, and cefixime capsules.